The Significance of Multidetector-Row Computed Tomography in the Preoperative Evaluation of Early Gastric Carcinoma

YAN Chao,ZHU Zheng-gang,YAN Min,CHEN Ke-min,CHEN Jun,XIANG Ming,CHEN Ming-min,LIU Bing-ya,YIN Hao-ran,LIN Yan-zhen

2008-01-01

Abstract:Objective To investigate the significance of multidetector-row computed tomography (MDCT) in the preoperative evaluation of early gastric carcinoma (EGC). Methods A total of 725 gastric carcinoma patients (including 115 patients with EGC) underwent preoperative MDCT examination. The results of MDCT were compared with corresponding pathological findings. Results The detection rate of primary tumor by MDCT was 74.8% (86/115) for EGC, and 99.2% (604/610) for advanced gastric carcinoma (AGC), respectively; there existed a significant difference (P=0.000). The tumor size of EGC patients whose primary tumor was detected by MDCT was larger than that of patients whose tumor was not detected by the same means(2.8 cm vs. 1.6 cm, P=0.000). Moreover, the incidence of lymph node(LN) metastasis in the former group was higher than that in the latter (20.9% vs. 3.5%, P=0.040). The accuracy of MDCT in differentiating EGC from AGC was 94.2% (683/725). Among those 86 EGC patients whose primary tumor was detected by MDCT, 59 cases were correctly staged, while the remaining 27 patients were overstaged as T2 or T3. There existed a significant difference between the two groups in terms of macroscopic typing (P=0.007) and layered pattern (P=0.000). Multivariate analysis by logistic regression showed that only layered pattern was closely related to the accuracy of MDCT in determining the T staging of EGC. The diagnostic sensitivity, specificity and accuracy of MDCT for determining LN metastasis of EGC were 73.7% (14/19), 85.4% (82/96), and 83.5% (96/115), respectively. The diagnostic sensitivity of MDCT for determining LN metastasis was 66.7% (10/15) in EGC patients with 4 metastatic LNs, while it was 100.0% (4/4) in those with ≥4 metastatic LNs. In 5 EGC cases of LN metastasis not detected by MDCT, their tumor sizes were all≥2 cm; and in 2 of the cases belonging to mucosal carcinomas, both were of the depressed types. In one EGC patient, a solitary metastasis smaller than 1 cm in the left liver was undetected by MDCT, while all the remaining 114 EGC patients were correctly staged as M0. Conclusions The clinical value of MDCT in the preoperative assessment of EGC is relatively high. Patients whose primary tumor has been detected by MDCT may be unfit to undergo minimally invasive therapy because of their higher incidence of LN metastasis and larger primary tumor size. In addition, because the diagnostic sensitivity of MDCT in determining LN metastasis is relatively low in patients with less than 4 metastatic LNs, the pay greater attention to LN metastasis-associated clinicopathological parameters in predicting the LN status shoud be pa, especially when minimally invasive therapy is being considered for these patients.